FIELD: medicine, pharmacology. SUBSTANCE: invention relates to the development of novel medicinal agents based on peptides and designated for treatment and prophylaxis of sicknesses of bacterial nature causing by staphylococcus aureus, pyocyanic bacillus, pneumococcus and others. Proposed agent comprises a linear hexapeptide of the structural formula: Leu-Val-Cys-Tyr-Pro-Gln and glycine in the ratio of components = (1:1)-(1:2) and agent is used in the dose 0.007 mg/kg of human weight. Invention allows the development of the novel medicinal agent without adverse effects and to develop method for its usage for treatment and prophylaxis of sicknesses caused by pathogens of bacterial nature. EFFECT: enhanced effectiveness and valuable medicinal properties of agent. 1 cl, 7 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF 4-(3-ETHOXY-4-HYDROXYBENZYL)-5-OXO-5,6-DIHYDRO-4H-[1,3,4]-THIADIAZIN-2-(2,4-DIFLUOROPHENYL) CARBOXAMIDE IN CRYSTALLINE FORM , AND USE THEREOF AS ANTIBACTERIAL AGENT FOR TREATING ACUTE, RECURRENT AND CHRONIC INFECTIONS | 2020 |
|
RU2737087C1 |
DRUG FOR TREATMENT OF INFECTIOUS DISEASES | 2019 |
|
RU2778522C2 |
METHOD FOR SIMULATING PREVENTION OF HOSPITAL STRAIN FORMATION | 2010 |
|
RU2458138C2 |
APPLICATION OF 4-(3-ETHOXY-4-HYDROXYBENZYL)-5-OXO-5,6-DIHYDRO-4H-[1,3,4]-THIADIAZINE-2-(2,4-DIFLUOROPHENYL)-CARBOXAMIDE TO SUPPRESS INFECTION, CAUSED BY ANTIBIOTIC-RESISTANT PSEUDOMONAS AERUGINOSA STRAINS, AND METHOD OF SUPPRESSION OF THIS INFECTION | 2016 |
|
RU2624846C1 |
VACCINE AGAINST INFECTIONS INDUCED BY OPPORTUNISTIC PATHOGENS | 2001 |
|
RU2204412C2 |
METHOD OF SUPPURATIVE-INFLAMMATORY PROCESS TREATMENT | 1993 |
|
RU2076703C1 |
ANTIBACTERIAL AGENT AND METHOD OF TREATING INTESTINAL YERSINIOSIS OR PSEUDOTUBERCULOSIS OR COLIBACTERIOSIS | 2013 |
|
RU2564014C2 |
COMPOSITION WITH ANTI-INFECTIOUS ACTIVITY | 2012 |
|
RU2476205C1 |
USE OF DALARGIN FOR PRODUCTION OF DRUG PREPARATIONS FOR PREVENTING PNEUMONIA | 2020 |
|
RU2728938C1 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
Authors
Dates
2003-08-20—Published
2002-09-13—Filed